from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2778c/-

LFCtreatmentdescriptionclass of inhibitor

-0.451

Amikacinug/mL Amikacintranslation

-0.225

Cap5-10ug/mL Capreomycintranslation

-0.826

Rox10-50 ug/mL Roxithromycintranslation

0.177

SM2-5 ug/mL Streptomycintranslation

-0.034

Tet5-10 ug/mL Tetracyclinetranslation

0.232

Rif0.2-5ug/mL Rifampicintranscription

-0.909

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.094

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.444

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.043

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.704

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.646

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.212

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.585

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.817

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.005

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.949

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.639

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.185

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.118

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.003

KCN5-20 ug/mL Potassium cyaniderespiration

-0.512

NaN30.2-2 mM Sodium aziderespiration

1.389

Nigericin50 uM Nigericinrespiration

-0.208

TRC10-150 ug/mL Triclosanrespiration

-1.474

TRZ10-25 ug/mL Thioridazinerespiration

-1.830

Valinomycin0.5-10 uM Valinomycinrespiration

1.047

ZnSO42 mM ZnSO4respiration

-0.787

menadione6-10 ug/mL Menadionerespiration

0.035

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.554

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.176

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.128

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.952

NRP_1Non-replicating persistence stage 1dosRassociated

0.508

Amp0.2mg/mL AmpicillincellWall

0.104

Cephalexin20-100 ug/mL CephalexincellWall

0.766

Cerulenin0.32-5 ug/mL CerulenincellWall

0.666

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.723

EMB10-20 ug/mL EthambutolcellWall

0.760

Eta12-40 ug/mL EthionamidecellWall

0.965

INH0.2-0.4 ug/mL IsoniazidcellWall

0.407

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.512

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.457

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.289

BZA0.12 mg/mL BenzamidearomaticAmides

0.344

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.102

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.716

H2O24 mM hydrogen peroxideDNAdamaging

-0.297

Levo10 ug/mL LevofloxacinDNAdamaging

0.591

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.462

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.148

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.417

UVUV-irradiationDNAdamaging

-0.707

ARP41-4 ug/mL Antitubercular compound ARP4?

0.932

Antimycin12.5-50 ug/mL Antimycin A?

0.147

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.533

PA_110-50 ug/mL Antitubercular compound PA-1?

0.719

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.089

PA8240.2-2 ug/mL PA-824?

-0.247

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.216

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.166

Verapamil50 uM Verapamil?

-0.278

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.683

methoxatin10-20 ug/mL Methoxatin?